MD, MPH
Associate Professor, Pathology and Laboratory Medicine
Associate Professor, Urology
Director of Surgical Pathology
Director of Genitourinary Pathology
UNC-Chapel Hill
Molecular Therapeutics
Area of Interest
My research involves the study of genitourinary malignancies, with the goal of translating histologic findings into molecular discoveries, with the ultimate aim of improving patient care. Specifically, I am focused on the molecular characterization of histologic variants of urothelial carcinoma. In addition to my own projects, I provide support to a wide variety of study types, including clinical trials, translational studies, basic science studies and animal models as the Faculty Director of the Pathology Services Core.
Awards and Honors
- UNC Junior Faculty Development Award, 2018-2019
News and Stories
Navigating cancer: Understanding tumor grades and stages
UNC Health oncologists and pathologist provide a basic overview of staging cancers and grading tumors, and why these categories are important to your medical team.
Genetic analysis of the most common type of bladder cancer in patients with metastatic disease yields guidance on treatment options
A genomic study of more than 200 people with the most common type of bladder cancer that has spread could help guide how the cancer would respond to immunotherapy.
